C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 209/08 (2006.01) A61K 31/40 (2006.01) A61K 31/41 (2006.01) A61K 31/44 (2006.01) A61K 31/50 (2006.01) A61K 31/53 (2006.01) A61K 31/535 (2006.01) A61K 31/695 (2006.01) C07C 235/46 (2006.01) C07C 255/54 (2006.01) C07D 213/82 (2006.01) C07D 213/85 (2006.01) C07D 235/06 (2006.01) C07D 235/26 (2006.01) C07D 249/18 (2006.01) C07D 263/58 (2006.01) C07D 285/14 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/12 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01)
Patent
CA 2232434
The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating Type II diabetes, comprising administering to a mammal in need thereof compounds of Formulas (I) and (II).
L'invention porte sur un secteur de la médecine concernant particulièrement le traitement du diabète II et de l'obésité et plus particulièrement sur un agoniste du récepteur adrénergique .beta.¿3? servant à traiter le diabète II et l'obésité, et sur des compositions et procédés de traitement du diabète II consistant à administrer à un mammifère le nécessitant des composés de formule (I) et (II).
Bell Michael Gregory
Crowell Thomas Alan
Droste Christine Ann
Jesudason Cynthia Darshini
Matthews Donald Paul
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Selective .beta.3 adrenergic agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective .beta.3 adrenergic agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective .beta.3 adrenergic agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1794997